# Phase II Study of Inhaled AeroLEF for Analgesia After ACL Knee Surgery

> **NCT00791804** · PHASE2 · COMPLETED · sponsor: **YM BioSciences** · enrollment: 19 (actual)

## Conditions studied

- Pain
- Post Operative Pain

## Interventions

- **DRUG:** AeroLEF

## Key facts

- **NCT ID:** NCT00791804
- **Lead sponsor:** YM BioSciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2004-06
- **Final completion:** 2004-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2008-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791804, "Phase II Study of Inhaled AeroLEF for Analgesia After ACL Knee Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00791804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*